![Jeffrey Farrow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Farrow
Directeur Financier/CFO chez
TARSUS PHARMACEUTICALS, INC.
Fortune : 4 M $ au 31/05/2026
Profil
Jeffrey S.
Farrow is currently an Independent Non-Executive Director at Clover Biopharmaceuticals Ltd. since 2021, a Director at Achieve Life Sciences, Inc. starting in 2026, and the Chief Financial & Strategy Officer at Tarsus Pharmaceuticals, Inc. since 2023.
Former roles include Chief Financial Officer, Director & Senior VP at Hyperion Therapeutics, Inc. from 2014 to 2015; Chief Accounting Officer & Vice President-Finance at Renovis, Inc. from 2004 to 2008; Chief Financial Officer at ZS Pharma, Inc. from 2015 to 2016; Senior Manager at KPMG LLP from 1996 to 2004; Vice President-Finance at Evotec SE from 2008 to 2010; Associate at Cooley Godward LLP; and Chief Financial & Accounting Officer at Global Blood Therapeutics, Inc. from 2020 to 2022.
Education includes an undergraduate degree from California State University-Fullerton, conferred in 1993.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/06/2026 | 56 801 ( 0,13% ) | 3 M $ | 31/05/2026 | |
| 02/04/2026 | 607 000 ( 0,05% ) | 151 028 $ | 31/05/2026 | |
| 29/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Jeffrey Farrow
| Sociétés | Poste | Début |
|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Directeur/Membre du Conseil | 19/04/2021 |
| TARSUS PHARMACEUTICALS, INC. | Directeur Financier/CFO | 24/04/2023 |
| ACHIEVE LIFE SCIENCES, INC. | Directeur/Membre du Conseil | 29/05/2026 |
Anciens postes connus de Jeffrey Farrow
| Sociétés | Poste | Fin |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Directeur Financier/CFO | 01/12/2022 |
| ZS PHARMA INC | Directeur Financier/CFO | 01/03/2016 |
| EVOTEC SE | Directeur Financier/CFO | 01/01/2010 |
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Comptroller/Controller/Auditor | 01/05/2008 |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Corporate Officer/Principal | 01/01/2004 |
Formation de Jeffrey Farrow
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
ZS Pharma, Inc.
 ZS Pharma, Inc. BiotechnologyHealth Technology Develops develop new treatments of kidney and liver diseases | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
Cooley Godward LLP
 Cooley Godward LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
California State University-Fullerton
 California State University-Fullerton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
Tarsus Pharmaceuticals, Inc.
 Tarsus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapeutic drugs for blepharitis | Health Technology |
Clover Biopharmaceuticals Ltd.
 Clover Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
